发明申请
- 专利标题: Ion channel modulating activity I
- 专利标题(中): 离子通道调节活性
-
申请号: US10914864申请日: 2004-08-09
-
公开(公告)号: US20050070552A1公开(公告)日: 2005-03-31
- 发明人: David Fedida , Gregory Beatch , Alan Ezrin , Peter Orth , Christian Hesketh
- 申请人: David Fedida , Gregory Beatch , Alan Ezrin , Peter Orth , Christian Hesketh
- 申请人地址: CA Vancouver
- 专利权人: Cardiome Pharma Corp.
- 当前专利权人: Cardiome Pharma Corp.
- 当前专利权人地址: CA Vancouver
- 主分类号: A61K31/40
- IPC分类号: A61K31/40 ; A61K31/455 ; A61K31/4965 ; A61K31/519 ; A61P9/06 ; C07D207/12
摘要:
Methods, compositions, dosing regimes, and routes of administration for the treatment or prevention of arrhythmias. In these methods, early afterdepolarizations and prolongation of QT interval may be reduced or eliminated by administering ion channel modulating compounds to a subject in need thereof. The ion channel modulating compounds may be cycloalkylamine ether compounds, particularly cyclohexylamine ether compounds. Also described are compositions of ion channel modulating compounds and drugs which induce early afterdepolarizations, prolongation of QT interval and/or Torsades de Pointes.
公开/授权文献
- US07674820B2 Ion channel modulating activity I 公开/授权日:2010-03-09
信息查询